Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Neurology

Volumn 74, Issue 16, 2010, Pages 1330-1331

  Rosenow, F ^a   Reif, P S ^a   Haag, A ^a   Schmidt, K ^a   Strik, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ENZYME INDUCING AGENT;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; GLIOBLASTOMA; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; SEIZURE; TUMOR BIOPSY; TUMOR VOLUME;

EID: 77951494531     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d8a5c2     Document Type: Letter

References (5)

1. KA Jaeckle K Ballman A Furth JC Buckner Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Neurology 73 2009 1207 1213
2. TF Cloughesy PY Wen HI Robins Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study J Clin Oncol 4 2006 3651 3656
3. S Oberndorfer M Piribauer C Marosi P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy J Neurooncol 72 2005 255 260
4. SB Green DP Byar MD Walker Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma Cancer Treat Rep 67 1983 121 132
5. A Pace L Bove P Innocenti Epilepsy and gliomas: incidence and treatment in 119 patients J Exp Clin Cancer Res 17 1998 479 482